We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
-16.6%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
AUM
$1.04B
AUM Growth
-$3.41M
Cap. Flow
+$220M
Cap. Flow %
21.29%
Top 10 Hldgs %
43.95%
Holding
852
New
247
Increased
177
Reduced
137
Closed
202

Sector Composition

Rank Sector Weight
1 Healthcare 28.69%
2 Financials 13.57%
3 Materials 7.25%
4 Technology 4.61%
5 Industrials 3.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CDTTW
376
CDT Equity Inc Warrant
CDTTW
$1.63M
$20K ﹤0.01%
+201,200
New +$28.4K
MSFT icon
377
CALL
Microsoft
MSFT
$3.76T
$20K ﹤0.01%
+30,000
New +$8.14M
LBBBR
378
DELISTED
Lakeshore Acquisition II Corp. Rights
LBBBR
$20K ﹤0.01%
+184,397
New +$35.4K
LFACW
379
DELISTED
LF Capital Acquisition Corp. II Warrants
LFACW
$20K ﹤0.01%
200,200
+125,200
+167% +$22.1K
TRAQ.WS
380
DELISTED
Trine II Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
TRAQ.WS
$20K ﹤0.01%
+134,901
New +$31.3K
AGAC.WS
381
DELISTED
African Gold Acquisition Corp Warrants
AGAC.WS
$20K ﹤0.01%
246,349
+221,349
+885% +$35K
KCAC.WS
382
DELISTED
Kensington Capital Acquisition Corp. IV Class 1 redeemable warrants, each exercisable for one Class A ordinary share at an exercise price of $11.50
KCAC.WS
$20K ﹤0.01%
+67,464
New +$25.2K
XLE icon
383
CALL
State Street Energy Select Sector SPDR ETF
XLE
$39.3B
$19K ﹤0.01%
205,600
+68,400
+50% +$2.74M
HCMAW
384
DELISTED
HCM Acquisition Corp Warrant
HCMAW
$19K ﹤0.01%
185,000
+20,250
+12% +$3.51K
VHAQ.RT
385
DELISTED
Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock
VHAQ.RT
$19K ﹤0.01%
235,333
+17,773
+8% +$2.37K
SVNAW
386
DELISTED
7 Acquisition Corp Warrant
SVNAW
$19K ﹤0.01%
+116,134
New +$27.4K
CRU.WS
387
DELISTED
Crucible Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
CRU.WS
$19K ﹤0.01%
188,451
+138,451
+277% +$25.7K
FE icon
388
CALL
FirstEnergy
FE
$27.1B
$18K ﹤0.01%
100,000
SMMT icon
389
Summit Therapeutics
SMMT
$11.9B
$18K ﹤0.01%
+18,049
New +$25.3K
XLV icon
390
CALL
State Street Health Care Select Sector SPDR ETF
XLV
$44B
$18K ﹤0.01%
+12,500
New +$1.64M
ALSAW
391
DELISTED
Alpha Star Acquisition Corp Warrants
ALSAW
$18K ﹤0.01%
446,921
+159,413
+55% +$8.34K
BWAQR
392
DELISTED
Blue World Acquisition Corporation Right
BWAQR
$18K ﹤0.01%
137,556
-20,800
-13% -$2.76K
HHLA.WS
393
DELISTED
HH&L Acquisition Co. Redeemable warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50
HHLA.WS
$18K ﹤0.01%
103,700
+73,700
+246% +$14.5K
BTWNW
394
DELISTED
Bridgetown Holdings Limited Warrants
BTWNW
$18K ﹤0.01%
+77,028
New +$28.9K
NHICW
395
DELISTED
NewHold Investment Corp. II Warrant
NHICW
$18K ﹤0.01%
91,805
-1,699
-2% -$421
TCDA
396
CALL
DELISTED
Tricida, Inc. Common Stock
TCDA
$18K ﹤0.01%
+15,000
New +$143K
AFAQW
397
DELISTED
AF Acquisition Corp Warrants
AFAQW
$18K ﹤0.01%
+125,300
New +$25.8K
HCARW
398
DELISTED
Healthcare Services Acquisition Corporation Warrant
HCARW
$18K ﹤0.01%
184,346
+33,606
+22% +$5.94K
BTMWW
399
DELISTED
Bitcoin Depot Inc Warrant
BTMWW
$17K ﹤0.01%
+185,800
New +$30.5K
BRACR
400
DELISTED
Broad Capital Acquisition Corp Rights
BRACR
$17K ﹤0.01%
220,662
+5,263
+2% +$765

Similar funds

Cowen and Company's Q2 2022 Portfolio in Review

As of Q2 2022, Cowen and Company held 852 positions worth $1.04B, down 0.33% from $1.04B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Cowen and Company deployed $220M of net new capital in Q2 2022, opening 247 new positions and adding to 177 existing holdings. Its largest new stake was Avidity Biosciences: 2,264,150 shares worth $32.9M.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 40% a quarter earlier, followed by Financials and Materials.

On the sell side, the largest reduction was Social Capital Hedosophia Holdings Corp. VI, an estimated $16.9M trimmed.

  • Cowen and Company's largest Q2 2022 buy was Avidity Biosciences: 2,264,150 shares worth $32.9M.
  • Cowen and Company added most to ARK Innovation ETF in Q2 2022, an estimated $72.6M increase.
  • Cowen and Company's biggest Q2 2022 reduction was Social Capital Hedosophia Holdings Corp. VI, cutting an estimated $16.9M.
  • Cowen and Company fully exited Rivian in Q2 2022, selling an estimated $26.8M.
  • Cowen and Company's ten largest holdings make up 44% of its $1.04B portfolio in Q2 2022.
  • Cowen and Company opened 247 new positions and closed 202 in Q2 2022.
  • Cowen and Company's portfolio value fell 0.33% quarter-over-quarter to $1.04B.

Based on Cowen and Company's 13F filing for Q2 2022, filed 5 Aug 2022.